改造IL-33mRNA的自身蛋白活性增强了腹膜癌症的采用T细胞治疗,并与IL-12mRNA协同作用
Leire Arrizabalaga1,2, Claudia Augusta Di Trani1,2, Celia Gomar1,2
1Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.
Theranostics
|January 29, 2026
概括
具有IL-33mRNA的工程T细胞促进腹癌的采用细胞疗法 (ACT). 这种方法增强了抗瘤免疫力和存活率,对治疗困难癌症有希望.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 基因治疗 基因治疗
背景情况:
- 腹癌 (PC) 是一个重大的治疗挑战.
- 采用细胞疗法 (ACT) 是有前途的,但受到免疫抑制瘤微环境 (TME) 的限制.
- 目前正在探索内ACT和细胞因子工程来克服这些局限性.
研究的目的:
- 在小鼠PC模型中评估IL-33 mRNA工程T细胞的疗效.
- 评估IL-33和IL-12mRNA在增强ACT中的潜在协同效应.
- 研究IL-33调节TME和T细胞反应的机制.
主要方法:
- T细胞 (OT.I,PMEL-1,CEA CAR) 是用IL-33和/或IL-12mRNA进行的.
- 在体外测试中评估了细胞因子的产生和细胞毒性.
- 在小鼠PC模型中的体内研究使用流细胞计,ELISA和ELISpot评估了生存率和免疫反应.
主要成果:
- 在PC模型中,IL-33 mRNA工程T细胞表现出增强的IFN-γ产生和改善的生存率.
- IL-33调节了TME,增加了有益的免疫细胞透和减少了中性粒细胞.
- 结合IL-33突变蛋白和IL-12mRNA,对T细胞功能和瘤控制产生了协同作用.
结论:
- IL-33通过自身隐性ST2信号传递和TME调制来增强ACT的疗效.
- 一个稳定的IL-33蛋白质改善了细胞因子的稳定性和抗瘤活性.
- 将IL-33与IL-12结合起来,为改善腹癌的ACT提供了一个协同策略.
相关概念视频
02:22Regulated mRNA Transport
7.0K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.0K
02:22Regulated mRNA Transport
3.4K
3.4K
02:01pre-mRNA Processing
57.4K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.4K
02:31Nuclear Export of mRNA
8.8K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.8K
02:31Nuclear Export of mRNA
5.4K
5.4K
02:27Nonsense-mediated mRNA Decay
11.8K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.8K